We hypothesize that SHH can bind to sex hormone receptors with its cholesterol modification but before any mechanistical studies, first we wanted to determine the expression of AR and SHH in breast cancer tissue samples from the Croatian population and examine potential correlations between this expression and clinical and pathological characteristics, especially BC molecular subtypes and receptors statuses. This evidence concerns the gene SHH and breast carcinoma.